Patent assignee · DE · COMPANY

BioNTech AG

37Patents
36Active
37Granted
53Portfolio score

Filing activity: Mar 14, 2003 → Feb 19, 2020 · 5 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9476055B2 Modification of RNA, producing an increased transcript stability and translation efficiency Human Necessities 22 Active
US9321808B2 Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers Human Necessities 22 Active
US9486519B2 Use of FLT3 ligand for enhancing immune responses in RNA immunization Chemistry; Metallurgy 14 Active
US8278262B2 Use of microproteins as tryptase inhibitors Chemistry; Metallurgy 11 Active
US9295717B2 Vaccine composition comprising 5′-cap modified RNA Human Necessities 11 Active
US10106800B2 Modification of RNA, producing an increased transcript stability and translation efficiency Human Necessities 11 Active
US8178653B2 Recombinant vaccines and use thereof Chemistry; Metallurgy 9 Active
US9175088B2 Identification of tumor-associated markers for diagnosing or monitoring ovarian cancer Chemistry; Metallurgy 8 Active
US9533043B2 Identification of surface-associated antigens for tumor diagnosis and therapy Physics 7 Active
US9194004B2 Identification of surface-associated antigens for tumor diagnosis and therapy Chemistry; Metallurgy 6 Active
US9267177B2 Identification of tumor-associated cell surface antigens for diagnosis and therapy Physics 6 Active
US10604568B2 Diagnosis and therapy of cancer involving cancer stem cells Physics 4 Active
US10717780B2 Agents for treatment of claudin expressing cancer diseases Chemistry; Metallurgy 3 Active
US10093736B2 Agents for treatment of claudin expressing cancer diseases Chemistry; Metallurgy 3 Active
US8945923B2 Antigen-specific clonal expansion of B cells Chemistry; Metallurgy 2 Active
US8258258B2 Dimeric or multimeric microproteins Human Necessities 2 Active
US10188712B2 Tumor antigens for determining cancer therapy Physics 2 Active
USD885517S1 Hydrogen water generator General 2 Active
US10980875B2 Cytotoxic immunostimulating particles and uses thereof Human Necessities 2 Active
US10370433B2 Compositions and methods for diagnosis and treatment of cancer Chemistry; Metallurgy 1 Active
US8980265B2 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) Chemistry; Metallurgy 1 Expired
US10253373B2 Identification of tumor-associated markers for diagnosis and therapy Chemistry; Metallurgy 1 Active
US8637006B2 Recombinant vaccines and use thereof Chemistry; Metallurgy 1 Active
US9636414B2 Particles comprising single stranded RNA and double stranded RNA for immunomodulation Human Necessities 1 Active
US10172960B2 Particles comprising single stranded RNA and double stranded RNA for immunomodulation Human Necessities 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.